FENC Bathi saben saham sajrone rolas wulan pungkasan Fennec

Fennec Pharmaceuticals (FENC) has created a unique protective environment for patient hearing by integrating Pedmark into pediatric therapy protocols. The rolling specific profit metric visualizes the market response, where the current level is -0.13. Growth is driven by the expansion of insurance coverage in the US and expansion into Europe, while its status as a niche monopolist guarantees a stable cash flow and operational resilience.

FENC (Fennec Pharmaceuticals) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 12.11.2026

Fennec Pharma - rincian analitis lan metrik utama (FENC)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Fennec Pharmaceuticals|FENC - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Nilai pasar Fennec Pharmaceuticals Inc.|FENC - Nilai Bisnis

- data nilai buku modal saham:

Nilai Buku saben Saham Fennec Pharmaceuticals|FENC - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku fennecpharma.com|FENC - Aset Perusahaan

- indikator beban utang lan likuiditas:

Utang marang Ekuitas Fennec Pharmaceuticals|FENC - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Fennec Pharmaceuticals Inc|FENC - Utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Fennec Pharmaceuticals Inc.|FENC - Tanggungan jangka dawa|Kewajiban jangka cendhak perusahaan Fennec Pharmaceuticals|Indikator likuiditas cepet fennecpharma.com

- indikator pendapatan resik lan kelipatan nilai:

FENC - Bathi pungkasan|Bathi mangsa ngarep Fennec Pharmaceuticals|FENC - Rasio rega pasar marang bathi resik|Pangali Forward P/E Fennec Pharmaceuticals Inc.|FENC - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Fennec Pharmaceuticals Inc.|FENC - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Fennec Pharmaceuticals|FENC - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan fennecpharma.com|FENC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Fennec Pharmaceuticals

Analisis dhasar perusahaan:Fennec Pharmaceuticals (FENC)

The efficiency of express delivery for oncology drugs to hospitals directly impacts the operational resilience of Fennec Pharmaceuticals (FENC). By analyzing the current annual net income per share, an investor can observe the 12-month earnings per share adjusted for the impact of share issuance, which allows them to filter out market noise and assess the business's real growth trajectory and its fundamental defensive qualities.

Analisis perusahaan pesaing